STOCK TITAN

10x Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
10x Genomics, Inc. (TXG) will release its financial results for Q4 and full year 2023 on February 15, 2024. The company will host a conference call and live webcast to discuss the results, business developments, and outlook. The webcast will be accessible on the company's website and archived for replay.
Positive
  • None.
Negative
  • None.

PLEASANTON, Calif., Jan. 24, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after market close on Thursday, February 15, 2024. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. The news release with the financial results will be accessible from the company's website prior to the conference call.

Live audio of the webcast will be available on the "Investors" section of the company website at: www.10xgenomics.com. The webcast will be archived and available for replay for at least 45 days after the event.

About 10x Genomics

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com 
Media: media@10xgenomics.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-15-2024-302043784.html

SOURCE 10x Genomics, Inc

FAQ

When will 10x Genomics release its financial results for Q4 and full year 2023?

10x Genomics will release its financial results on February 15, 2024.

What is the ticker symbol for 10x Genomics?

The ticker symbol for 10x Genomics is TXG.

Where can I access the live webcast of the conference call?

The live webcast will be available on the 'Investors' section of the company website at www.10xgenomics.com.

How long will the webcast be available for replay?

The webcast will be archived and available for replay for at least 45 days after the event.

10x Genomics, Inc.

NASDAQ:TXG

TXG Rankings

TXG Latest News

TXG Stock Data

3.15B
102.65M
2.38%
92.4%
7.15%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
PLEASANTON

About TXG

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.